Higher hemoglobin levels decrease transfusion risk in predialysis patients with CKD
Objectives:
Anemia is one of the major complications in predialysis patients with chronic kidney disease (CKD). A clearer cognition of the prognostic impact of hemoglobin (Hb) or hematocrit (Hct) target on the outcomes of predialysis patients with CKD is significant. Therefore, this review article (meta-analysis) has been conducted.
Does higher hemoglobin levels decrease transfusion risk in predialysis patients with CKD?